You Position: Home > Paper

Bortezomib:a proteasome inhibitor in the treatment of multiple myeloma

( views:327, downloads:72 )
Author:
No author available
Journal Title:
JOURNAL OF LEUKEMIA & LYMPHOMA
Issue:
5
DOI:
10.3760/cma.j.issn.1009-9921.2008.05.003
Key Word:
多发性骨髓瘤;蛋白酶抑制药;Multiple myeloma;Protease inhibitor

Abstract: Proteasome inhibitor bortezomib has a very powerful anti-myeloma effect on both preclinical and clinical trails.it has been widely used in the treatment of newly diagnosed,refractory and relapse multiple myeloma.Its side effects were well tolerant and manageable.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn